These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32749013)

  • 1. Use of psoralen therapies obtained abroad in two children with Vitiligo.
    Bell KA; Saardi KM; Norton SA; Habeshian KA
    Pediatr Dermatol; 2020 Sep; 37(5):922-924. PubMed ID: 32749013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
    Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
    Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemotherapy (PUVA) in psoriasis and vitiligo.
    Shenoi SD; Prabhu S;
    Indian J Dermatol Venereol Leprol; 2014; 80(6):497-504. PubMed ID: 25382505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postburn leukoderma successfully treated with topical daylight psoralen UVA therapy.
    Alzahrani Z; Ghobara YA; AlJasser MI
    Dermatol Ther; 2020 Mar; 33(2):e13248. PubMed ID: 32020719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study.
    Kwok YK; Anstey AV; Hawk JL
    Clin Exp Dermatol; 2002 Mar; 27(2):104-10. PubMed ID: 11952699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of PUVAsol and topical calcipotriol in vitiligo.
    Parsad D; Saini R; Verma N
    Dermatology; 1998; 197(2):167-70. PubMed ID: 9732168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accidental PUVA burns, vitiligo and atopic diathesis resulting in prurigo nodularis: a logical but undocumented rarity.
    Verma SB; Wollina U
    An Bras Dermatol; 2012; 87(6):891-3. PubMed ID: 23197209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
    Lee Y; Seo YJ; Lee JH; Park JK
    Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients.
    Handa S; Pandhi R; Kaur I
    J Dermatol; 2001 Sep; 28(9):461-6. PubMed ID: 11603385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoralen phototherapy and phototoxicity.
    Berakha GJ; Lefkovits G
    Ann Plast Surg; 1985 May; 14(5):458-61. PubMed ID: 4083703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for vitiligo.
    Whitton ME; Ashcroft DM; Barrett CW; Gonzalez U
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003263. PubMed ID: 16437451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
    Khalid M; Mujtaba G; Haroon TS
    Int J Dermatol; 1995 Mar; 34(3):203-5. PubMed ID: 7751099
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Science and (Lost) Art of Psoralen Plus UVA Phototherapy.
    Richard EG
    Dermatol Clin; 2020 Jan; 38(1):11-23. PubMed ID: 31753184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches.
    Parsad D; Pandhi R; Dogra S; Kumar B
    J Am Acad Dermatol; 2004 Jan; 50(1):63-7. PubMed ID: 14699367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands.
    Njoo MD; Bossuyt PM; Westerhof W
    Int J Dermatol; 1999 Nov; 38(11):866-72. PubMed ID: 10583624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.